Premarket Movers | Cidara Therapeutics Surges 67%; Quantum Shares Slide With Rigetti Computing Down Nearly 6%; Applied Digital, Opendoor Fall 4% Each

Tiger Newspress
Nov 14

Cidara Therapeutics shares rose 67% in premarket trading. Merck is closing in on a deal to buy Cidara Therapeutics in a deal valuing the biotechnology company at a premium to its $3.3 billion market capitalization, the Financial Times reported on Thursday.

Figure Technology Solutions shares climbed over 5% in premarket trading after the blockchain-based lender turned in Q3 revenue that easily beat the Wall Street consensus, marking its first quarter as a public company.

Q3 adjusted net revenue of $156.4M, exceeding the $119.4M average analyst estimate, advanced 42% from the year-earlier period. Net income of $90M surged 227% Y/Y.

Applied Digital stock fell 4% in premarket trading after announcing the pricing of a $2.35 billion offering of 9.250% senior secured notes due 2030, issued at 97% of face value.

Quantum shares slid in premarket trading. Rigetti Computing down nearly 6%; SEALSQ, D-Wave Quantum down over 4%; Quantum Computing down over 3%.

Opendoor Technologies Inc shares fell over 4% in premarket trading after plunging 8% on Thursday, pausing a recent rally as negative sentiment ripples through the property technology sector. The pullback coincides with a disappointing third-quarter earnings report from peer Better Home & Finance, which missed analyst estimates. The two companies are often linked in investor sentiment; hedge fund manager Eric Jackson recently touted both as high-potential growth plays.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10